Recurrence of Low-risk Non-muscle-invasive Bladder Cancer in Patients Who Did Not Receive Immediate Intravesical Chemotherapy
The recurrence rate was high in low-risk patients with NMIBC who did not receive immediate IVC, and a subset of patients progressed to more aggressive disease. These findings underscore the potential benefit of introducing immediate IVC in this population.
Authors
- Takuo Matsukawa (ORCID: https://orcid.org/0009-0009-4418-399X)
- Akinori MINATO
- Eiji Kashiwagi (ORCID: https://orcid.org/0000-0002-4855-1042)
- Yui Mizushima
- Rieko Kimuro
- K. Jojima
- Ikko Tomisaki
- Katsuyoshi Higashijima
- Yujiro Nagata
- Shuki Watanabe
- Yoshihiro Sugita
Institutions
- University of Occupational and Environmental Health Japan (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2026-01-03
- DOI
- https://doi.org/10.21873/cdp.10514
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science